Tratamiento antiarrítmico farmacológico en fase crónica de la fibrilación auricular

Kannel, 1982, Epidemiologic features of chronic atrial fibrillation: the Framingham study, New Engl J Med, 306, 1018, 10.1056/NEJM198204293061703 Krahn, 1995, The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study, Am J Med, 98, 476, 10.1016/S0002-9343(99)80348-9 Mason, 2005, Influence of the randomized trials. AFFIRM and RACE, on the management of atrial fibrillation in two University Medical Centers, Am J Cardiol, 95, 1248, 10.1016/j.amjcard.2005.01.059 Opolski, 2003, Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study, Kardiologia Polska, 59, 1 Van Gelder, 2002, A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation, New Engl J Med, 347, 1834, 10.1056/NEJMoa021375 Ogawa, 2009, Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study, Circ J, 73, 242, 10.1253/circj.CJ-08-0608 Roy, 2008, Rhythm control versus rate control for atrial fibrillation and heart failure, New Engl J Med, 358, 2667, 10.1056/NEJMoa0708789 Jenkins, 2005, Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study, Am Heart J, 149, 112, 10.1016/j.ahj.2004.03.065 Hagens, 2005, Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study, Am Heart J, 149, 1106, 10.1016/j.ahj.2004.11.030 Hagens, 2005, Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study, Heart Rhythm, 2, 19, 10.1016/j.hrthm.2004.09.028 Camm, 2012, An update of the 2010 ESC Guidelines for the management of atrial fibrillation, Eur Heart J, 33, 2719 McNamara, 2003, Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography, Ann Intern Med, 139, 1018, 10.7326/0003-4819-139-12-200312160-00012 Alboni, 2004, Outpatient treatment of recent-onset atrial fibrillation with the “pill-in-the-pocket” approach, New Engl J Med, 351, 2384, 10.1056/NEJMoa041233 Singh, 2005, Amiodarone versus sotalol for atrial fibrillation, New Engl J Med, 352, 1861, 10.1056/NEJMoa041705 Singh, 2010, Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium?, J Am Coll Cardiol, 55, 1569, 10.1016/j.jacc.2009.10.071 Singh, 2007, Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter, New Engl J Med, 357, 987, 10.1056/NEJMoa054686 Lewalter, 2010, Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation, J Am Coll Cardiol, 55, 1051, 10.1016/j.jacc.2009.10.037 Cook, 2010, Atrial fibrillation. DIONYSOS study comparing dronedarone with amiodarone, BMJ (Clin Res ed.), 340, c285, 10.1136/bmj.c285 Naccarelli, 2010, A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission, J Cardiovasc Pharmacol Ther, 15, S24, 10.1177/1074248410368276 Hohnloser, 2009, Effect of dronedarone on cardiovascular events in atrial fibrillation, New Engl J Med, 360, 668, 10.1056/NEJMoa0803778 Connolly, 2011, Dronedarone in high-risk permanent atrial fibrillation, New Engl J Med, 365, 2268, 10.1056/NEJMoa1109867 Rathore, 2003, Association of serum digoxin concentration and outcomes in patients with heart failure, JAMA, 289, 871, 10.1001/jama.289.7.871 Van Gelder, 2010, Lenient versus strict rate control in patients with atrial fibrillation, New Engl J Med, 362, 1363, 10.1056/NEJMoa1001337 Davy, 2008, Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study, Am Heart J, 156, e1